Understanding how aging beta cells affect diabetes
The role of senescent beta cells in T1D and T2D
This study is looking at how aging cells in the pancreas might affect diabetes, and it's for anyone interested in understanding more about Type 1 and Type 2 diabetes, with the hope of finding better ways to help manage the condition.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10891486 on NIH RePORTER |
What this research studies
This research investigates the role of aging beta cells in the development and progression of Type 1 and Type 2 diabetes. By examining human pancreatic tissue, the study aims to identify the prevalence and characteristics of senescent beta cells, which may contribute to islet dysfunction. The researchers will utilize advanced techniques such as single-cell RNA sequencing and imaging mass cytometry to analyze these cells and their impact on diabetes. The findings could lead to new insights into how to improve beta cell function and overall diabetes management.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with Type 1 or Type 2 diabetes, particularly those experiencing complications related to beta cell dysfunction.
Not a fit: Patients without diabetes or those whose diabetes is well-managed and stable may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to innovative treatments that restore beta cell function and improve diabetes outcomes.
How similar studies have performed: Previous studies have shown promise in targeting senescent cells in animal models, suggesting potential for similar success in human applications.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Kaestner, Klaus H — University of Pennsylvania
- Study coordinator: Kaestner, Klaus H
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.